PTC THERAPEUTICS, INC. — Director's Dealing 2015

Mar 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-03-09

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-09	Common Stock	S	43601	$70.67	Disposed	50800	Direct
2015-03-09	Common Stock	S	3200	$71.48	Disposed	47600	Direct
2015-03-09	Common Stock	S	400	$72.27	Disposed	47200	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan entered into on August 14, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.11 to $71.10 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.14 to $71.99 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.20 to $72.33 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.